Haemopharm Healthcare

What Haemopharm Healthcare does

Haemopharm Healthcare is a privately held Italian manufacturing company headquartered in Crotone, Italy, that produces bags for sterile products and infusion components for medical applications. Founded in 1979, the company has operated in the medical consumables segment for over four decades, supplying components used in sterile fluid handling and infusion therapy. Its product portfolio centers on sterile containment and delivery components — a category serving hospital, clinical, and pharmaceutical customers that require validated, regulated medical-grade materials.

The company operates as a small-scale specialist manufacturer with a headcount of 11-50 employees, consistent with a focused niche producer rather than a broad-line medical devices conglomerate. Its go-to-market appears to be direct or distributor-based B2B sales into the medical supply chain, though specific customer names, channel structure, and pricing mechanics are not disclosed in the available source data. No funding rounds, ownership structure, certifications, or management team details are publicly available in the input.

Critically, the source data for this analysis is sparse — the company's own website returned only a verification/loading page during scraping, and third-party enrichment returned no financials, no product catalogue, no management bios, and no partnership information. Consequently, business model mechanics (pricing, margins, contract structures) and competitive positioning cannot be evidenced beyond the high-level firmographic and product-category description. The investment-relevant signal is that Haemopharm is a long-tenured, privately held Italian medical consumables manufacturer with no disclosed growth signals, M&A activity, or capital-raising history in the available record.

Name

Haemopharm Healthcare

Website

https://haemopharm.it

Company type

Private

Founded year

1979

Headcount range

11–50 employees

Short description

Haemopharm Healthcare is a privately held Italian manufacturer, founded in 1979 and based in Crotone, that produces sterile bags and infusion components for medical applications, serving healthcare and pharmaceutical customers with a small specialized workforce of 11-50 employees.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Plastics Bag and Pouch Manufacturing (326111), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Plastics, Foil & Coated Paper Bags (2673), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

akta.pro secondary industry

Medical & Pharmaceutical Thermoformed Packaging (IMANAHAB)

Keywords

• Sterile fluid bags
• Infusion components
• Medical device manufacturing
• IV therapy supplies
• Pharmaceutical packaging

Headquarters

HQ city

Crotone

HQ country

Italy

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure

Core offering

Haemopharm Healthcare manufactures bags for sterile products and infusion components for medical applications. The company produces physical medical device components used in sterile fluid delivery and IV/injection therapies. Its offerings are targeted at healthcare providers and pharmaceutical supply chains requiring reliable sterile containment solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Sterile product bags
• Infusion components

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• B. Braun Melsungen: One of the world's largest manufacturers of infusion solutions, IV bags, and sterile medical packaging. While far larger and broader in portfolio than Haemopharm, B. Braun competes directly in the same sterile-bag and infusion-component categories that Haemopharm serves, and is also a potential acquirer of smaller specialized manufacturers in this space.
• Fresenius Kabi: Global medical device and infusion therapy company producing IV solutions, sterile bags, infusion sets, and clinical nutrition products. Directly comparable to Haemopharm's product lines at the OEM level, though operating at vastly greater scale and geographic reach across Europe and beyond.
• Baxter International: Major manufacturer of IV bags, sterile solutions, and infusion systems widely used in hospitals globally. Overlaps directly with Haemopharm's sterile-bag and infusion-component focus and represents the kind of large incumbent whose pricing and supply-chain practices shape the addressable market for smaller European manufacturers.
• Terumo: Global medical device company with a strong portfolio in blood bags, infusion therapy, and sterile medical components. Comparable to Haemopharm in the blood/infusion sterile-bag category, though with substantially broader product range and a global commercial footprint.
• Grifols: Global healthcare company with operations in sterile bag manufacturing for blood/plasma collection and infusion-related disposables. Comparable to Haemopharm in the sterile-container-for-clinical-fluids category, though at substantially greater scale and with broader plasma-therapy operations.
• Haemonetics: Medical device company focused on blood and plasma component management, including blood collection and processing disposables. Adjacent to Haemopharm's sterile-bag and infusion-component focus, particularly on the blood-product side of the company's portfolio.

Direct peers

• MacoPharma: French-headquartered manufacturer specializing in blood collection bags, transfusion sets, and sterile infusion disposables. Closely aligned with Haemopharm in both product type (sterile bags) and customer base (hospital transfusion and infusion departments), making it the most directly comparable peer by scope and scale.
• Polycine GmbH: European manufacturer of medical-grade plastic films, pouches, and bags for sterile medical device packaging. Directly comparable to Haemopharm's sterile-bag manufacturing focus, with a similar specialty-supplier positioning serving medical device OEMs in the EU.
• Renolit Group: European manufacturer of medical-grade films and laminates used in sterile medical packaging, including IV bag and pouch applications. A close functional peer to Haemopharm's bag-manufacturing activity, supplying similar materials and components into the medical packaging value chain.

Emerging players

• AdvaCare Pharma: Manufacturer and distributor of medical consumables including IV infusion bags and sterile medical disposables, with growing presence in European and emerging markets. Comparable to Haemopharm in infusion-bag product category, though with a broader distribution-led model and a more diverse geographic footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/Haemopharm
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haemopharm Healthcare